Pfizer stock price edges up — what PFE investors are watching after vaccine policy shifts
New York, January 22, 2026, 20:16 EST — Market closed
Pfizer shares ended Thursday up 0.8%, closing at $26.10 after climbing Wednesday. The stock stayed comfortably within the mid-$20s, fluctuating between $25.75 and $26.31 during the session. (StockAnalysis)
The move came as vaccine makers assessed rapid policy changes in the U.S. under Health Secretary Robert F. Kennedy Jr., a shift now creeping into investor talks and sector bets. “Vaccines will not be a growth area under the current administration,” said Stephen Farrelly, ING’s global pharma and healthcare lead. Pfizer CEO Albert Bourla expressed being “seriously frustrated,” blaming the rhetoric for declining vaccination rates. (Reuters)
This week,…
